|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 47/48 | |||
| A61K 39/395 | |||
| A61P 3/02 | |||
| A61P 7/06 |
| (11) | Number of the document | 2335719 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10196139.9 |
| Date of filing the European patent application | 2006-02-16 | |
| (97) | Date of publication of the European application | 2011-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2015-06-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 653479 P | 2005-02-16 | US |
| (72) |
Lin, Herbert Y, US
Babitt, Jodie, US
Chung, Raymond T, US
Samad, Tarek, A., US
Schneyer, Alan, L., US
Woolf, Clifford, US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
|
| (54) | Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |